Dopamine agonists in Parkinson's disease

Expert Review of Neurotherapeutics
Mitsutoshi Yamamoto, A H V Schapira

Abstract

Dopamine agonists are established as effective drugs for the symptomatic treatment of Parkinson's disease (PD) throughout its course. As monotherapy, they produce effective control of motor symptoms and combine this with a low risk for motor complications. As an adjunct to levodopa, they improve motor control and limit the need for levodopa in those patients in whom this may be considered relevant. The non-ergot dopamine agonists in particular have a good safety profile, although as with other agonists, sedation, and cognitive and behavioral problems may be limiting in some patients. Pramipexole has shown benefit in improving depressive symptoms in PD. Ropinirole and pramipexole have both demonstrated a reduction in the rate of loss of nigrostriatal innervation as determined by imaging in PD patients, when compared with levodopa. Thus, dopamine agonists contribute to several dimensions of the management of PD and have become an integral part of the disease treatment algorithm.

References

Mar 1, 1985·Neurology·S G DiamondL J Treciokas
Aug 1, 1985·Acta Neurologica Scandinavica·Y ToyokuraH Ito
Jan 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·C W OlanowJ Jankovic
Jan 1, 1997·Journal of Neural Transmission·P M CarveyZ D Ling
Sep 28, 1998·Annals of Neurology·C W OlanowD Brooks
Jan 29, 1999·BMJ : British Medical Journal·A H Schapira
May 17, 2000·Depression and Anxiety·M H CorriganD L Evans
Sep 12, 2000·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·A M DamianoE D Means
Oct 29, 2000·Trends in Neurosciences·J A ObesoJ G Nutt
Oct 29, 2000·Trends in Neurosciences·W OlanowO Rascol
Mar 26, 2002·Brain : a Journal of Neurology·Andrew J HughesAndrew J Lees
Apr 3, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN Parkinson Study Group
Oct 11, 2002·Archives of Neurology·Clifford W ShultsUNKNOWN Parkinson Study Group
Jun 5, 2003·Clinical Neuropharmacology·Thomas Müller, Jürgen Fritze
Jul 3, 2003·Annals of Neurology·Alan L WhoneUNKNOWN REAL-PET Study Group
Jan 22, 2004·JAMA : the Journal of the American Medical Association·Anthony H V Schapira, C Warren Olanow
May 26, 2004·Lancet Neurology·Anthony H V Schapira
Oct 27, 2004·Neurology·Anthony H Schapira
Dec 1, 2004·Journal of Neurochemistry·Mei GuAnthony H V Schapira
Dec 14, 2004·The New England Journal of Medicine·Stanley FahnUNKNOWN Parkinson Study Group
Apr 9, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Christopher G GoetzCristina Sampaio
Oct 8, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Wolfgang H OertelJohannes Schwarz
Feb 9, 2006·Journal of Neurochemistry·Mahmoud M IravaniAnthony H Schapira
Feb 21, 2006·Lancet Neurology·K Ray ChaudhuriUNKNOWN National Institute for Clinical Excellence

❮ Previous
Next ❯

Citations

Aug 4, 2012·ACS Chemical Neuroscience·Brian C Shook, Paul F Jackson
Jun 18, 2014·Brain : a Journal of Neurology·Elena DragicevicBirgit Liss
Dec 18, 2008·Expert Review of Neurotherapeutics·David B Sommer, Mark A Stacy
May 19, 2009·Parkinsonism & Related Disorders·P JennerJ F Chen
Oct 21, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Leena SubramanianDavid E J Linden
Aug 30, 2011·Journal of Affective Disorders·Stefanie C LindenDavid E J Linden
Jun 11, 2009·Psychiatric Genetics·Alexandra DoehringJörn Lötsch
Mar 20, 2010·Biochemical Society Transactions·Vincenza BagettaBarbara Picconi
Apr 11, 2019·Drugs·Margherita TortiFabrizio Stocchi
Oct 30, 2013·Journal of Medicinal Chemistry·Manuel de Lera RuizJunying Zheng
Nov 20, 2018·Neuro-degenerative Diseases·Spyros PapapetropoulosDavid L Gray

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved